
    
      This study plans to include those subjects who have complaint of peripheral microvascular
      symptoms but have evidences of having neither a coronary arterial disease nor a peripheral
      arterial disease and show normal findings in the vascular stiffness test (PWV and ABI)) and
      plethysmography of the legs (PVR)) ,among Type II diabetes mellitus patients of forty-five
      (45) years old or older, This study is conducted by using a randomized double blind method.
      These drugs are distributed through a pharmacy in the clinical study center and administered
      randomly for eight weeks while this study allots patients by using a double blind method.
      Beraprost Na is administered along with a placebo that was manufactured by the same
      manufacturer to have the identical exterior look and weight of Beraprost Na. After eight
      weeks of drug administration, this investigation attempts to verify symptomatic improvement
      and change in the endothelial function by using VENDYSÂ® and ICG perfusion imaging.
    
  